WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005066165) N-SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/066165    International Application No.:    PCT/IB2004/004239
Publication Date: 21.07.2005 International Filing Date: 20.12.2004
Chapter 2 Demand Filed:    17.01.2005    
IPC:
C07D 403/14 (2006.01), C07D 409/14 (2006.01), C07D 413/14 (2006.01), C07D 417/14 (2006.01)
Applicants: WARNER-LAMBERT COMPANY LLC [US/US]; 201 Tabor Road, Morris Plains, NJ 07950 (US) (For All Designated States Except US).
CHO, Stephen, Sung, Yong [US/US]; (US) (For US Only).
GREGORY, Tracy, Fay [US/US]; (US) (For US Only).
GUZZO, Peter, Robert [US/US]; (US) (For US Only).
HOWARD, Harry, Ralph, Jr. [US/US]; (US) (For US Only).
NIKAM, Sham, Shridhar [IN/US]; (US) (For US Only).
SURMAN, Matthew, David [US/US]; (US) (For US Only).
WALTERS, Michael, Anthony [US/US]; (US) (For US Only)
Inventors: CHO, Stephen, Sung, Yong; (US).
GREGORY, Tracy, Fay; (US).
GUZZO, Peter, Robert; (US).
HOWARD, Harry, Ralph, Jr.; (US).
NIKAM, Sham, Shridhar; (US).
SURMAN, Matthew, David; (US).
WALTERS, Michael, Anthony; (US)
Agent: FEDERMAN, Evan, J.; Pfizer Inc., 201 Tabor Road, Morris Plains, NJ 07950 (US)
Priority Data:
60/533,761 31.12.2003 US
Title (EN) N-SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES
(FR) DERIVES DE PIPERIDINE ET DE PIPERAZINE N-SUBSTITUES
Abstract: front page image
(EN)This invention relates to compounds of the formula 1 wherein R1, R2, R7, R8, R9, U, V, Z, A, W, X, M, E, L, T and D are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.
(FR)L'invention concerne des composés représentés par la formule 1, dans laquelle R1, R2, R7, R8, R9, U, V, Z, A, W, X, M, E, L, T et D sont tels que définis dans la spécification, des compositions pharmaceutiques contenant ces composés et leur utilisation dans le traitement, entre autres, de maladies du système nerveux central.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)